Study of the mechanical properties of diseased blood vessel tissues

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the mechanical properties of atherosclerotic plaque from human carotid and femoral arteries, as well as abdominal aortic aneurysm tissue. It aims to correlate these tissue mechanics with novel blood-based biomarkers related to cardiovascular calcification. The study involves patients undergoing standard surgical procedures for plaque removal, allowing for the collection and analysis of tissue samples without any experimental interventions. The findings could enhance understanding of vascular diseases and their biomarkers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with arterial plaque undergoing treatment where the plaque tissue will be surgically removed as per the usual peripheral endarterectomy procedure.
* Able to provide informed consent.

Exclusion Criteria:

* Patients that are unable to give informed consent.
* Seriously ill/unconscious patients.

Where it's running

• University Hospital Limerick
  Limerick, Limerick, Ireland Recruiting

Study contacts

• Study coordinator: Fiona Leahy, MSc
• Email: fionac.leahy@hse.ie
• Phone: 061 301111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• Road-mapping versus ultrasound guidance for retrograde arterial puncture during angioplasty

  This trial will test whether using road mapping or ultrasound to guide retrograde arterial puncture works better and is safer for adults with critical limb-threatening ischemia who need retrograde access during angioplasty.

  Recruiting Sohag University · Sohag · NCT07427108

• Mosliciguat added to inhaled treprostinil for pulmonary hypertension from ILD

  This trial tests whether adding inhaled mosliciguat to your inhaled treprostinil is safe and tolerable for people with pulmonary hypertension caused by interstitial lung disease.

  Recruiting at 13 sites Phase 2 Pulmovant, Inc. · Santa Barbara, California and 12 other locations · NCT07333183

• Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease

  This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.

  Recruiting at 10 sites Fundación EPIC · Boston, Massachusetts and 14 other locations · NCT07286578

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

• RADIANCE CED: long-term outcomes after ultrasound renal denervation

  This project will see if ultrasound renal denervation (using the Paradise system) lowers blood pressure over the long term in Medicare-age adults (65+) with uncontrolled hypertension by using their medical records.

  Recruiting at 2 sites ReCor Medical, Inc. · Detroit, Michigan and 1 other locations · NCT07231757

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.